| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
9e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.22 |
3e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |